Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Early and accurate classification of breast tumors from MRI scans is essential for improving patient outcomes. However, a key limitation of conventional deep learning models, such as Convolutional Neural Networks (CNNs), is their difficulty in capturing the subtle, spatially variant features that are crucial for precise medical image interpretation. OBJECTIVE: To address this limitatio...
Histone deacetylase 8 (HDAC8), a pivotal epigenetic regulator orchestrating chromatin remodeling and transcriptional control, has emerged as a compelling anticancer target owing to its frequent dysregulation in malignancies. The development of isoform-selective inhibitors, however, confronts substantial challenges because of the pronounced structural conservation across HDAC isoforms. This study d...
Postoperative recurrence and metastasis in esophageal squamous cell carcinoma (ESCC) are closely associated with cancer stem cells (CSCs), though the ...
The advent of immunotherapy and targeted therapy has revolutionized oncology treatment in recent years, marking a transformative shift toward precisio...
BACKGROUND: Complete cytoreduction is the most important prognostic factor for patients with peritoneal surface malignancies (PSM) and its prediction ...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. It is often diagnosed at advanced stages and characterized by high recu...
Lipid nanoparticle (LNP)-mRNA technology has profoundly transformed the biomedical landscape, establishing itself as a highly versatile and powerful p...
Radiation necrosis (RN) remains a challenging complication of upfront radiation therapy for both brain metastases and primary tumors. Despite developm...
Monoclonal gammopathies span a continuum from monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) to overt...
PURPOSE: Differentiating conjunctival intraepithelial neoplasia (CIN) from pterygium and pseudopterygium remains clinically challenging, especially in...
BACKGROUND: Uncertainty around a patient's prognosis at the end of life remains a major barrier to timely palliative-care involvement and alignment of...
OBJECTIVES: To construct a multimodal model integrating computed tomography (CT) imaging, radiotherapy dose, and clinical features to address the clin...
BACKGROUND: Recurrent glioblastoma multiforme (rGBM) arises after conventional treatment strategies for primary GBM (pGBM) fail, leading to a more agg...
Early prediction of malignant pleural effusion (MPE) recurrence within 3 months is essential for optimizing management in lung cancer patients. This s...
Minimal/measurable residual disease detection is routinely performed as part of post-diagnostic treatment plans for many types of cancer, for which mu...
Biochemical recurrence (BCR) is a critical factor affecting the prognosis of prostate cancer (PCa) patients, while T cell exhaustion and metastatic pr...
BACKGROUND: Early detection of hepatocellular carcinoma (HCC) remains a significant clinical challenge due to the limited sensitivity of current surve...
PURPOSE: Germline pathogenic variants (GPV) are frequently identified as secondary findings in cancer gene panel testing. Due to limited data on germl...
Immune checkpoint inhibitors and anti-angiogenic targeted therapies have improved outcomes in hepatocellular carcinoma (HCC), but responses remain het...